Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.38 |
| ▸ | ADA | P00813 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | EIF4E | P06730 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4079004 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAALBMAPK1CYP1A2 | |
| SCHEMBL4078996 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAALBMAPK1CYP1A2 | |
| SCHEMBL18963574 | 0.80 | ABL1 (0.35) | ALDH1A1LMNAALBMAPK1CYP1A2 | |
| SCHEMBL9234363 | 0.77 | ALDH1A1 (0.42) | ALDH1A1LMNAALBMAPK1CYP1A2 | |
| SCHEMBL2193016 | 0.76 | ADRB1 (0.50) | LMNAADASMN1; SMN2ADORA1HTT | |
| SCHEMBL149648 | 0.76 | ADRB1 (0.50) | LMNAADASMN1; SMN2ADORA1HTT | |
| SCHEMBL13186252 | 0.73 | LMNA (0.54) | ALDH1A1LMNAALBMAPK1CYP1A2 | |
| SCHEMBL13886984 | 0.73 | LMNA (0.54) | ALDH1A1LMNAALBMAPK1CYP1A2 | |
| SCHEMBL11996917 | 0.73 | LMNA (0.54) | ALDH1A1LMNAALBMAPK1CYP1A2 | |
| SCHEMBL30364250 | 0.73 | KDM5A (0.43) | ADA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7491818-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2009-02-17 | — | — | US | disclosed |
| US-7423143-B2 | Nucleic acid labeling compounds | AFFYMETRIX. INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-7291463-B2 | Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis | AFFYMETRIX, INC. (US) | 2007-11-06 | — | — | US | disclosed |
| US-7282327-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-7179905-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-20050287563-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2005-12-29 | — | — | US | disclosed |
| US-6965020-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2005-11-15 | — | — | US | disclosed |
| EP-1589025-A2 | Nucleic acid labeling compounds | Affymetrix, Inc. (US) | 2005-10-26 | — | — | EP | disclosed |
| US-20050164268-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2005-07-28 | — | — | US | disclosed |
| EP-1124838-B1 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX INC (US) | 2005-06-01 | — | — | EP | disclosed |
| US-20040101892-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2004-05-27 | — | — | US | disclosed |
| US-20040002595-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2004-01-01 | — | — | US | disclosed |
| US-20030232979-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2003-12-18 | — | — | US | disclosed |
| US-6596856-B2 | For probes, comprising a heterocycle condensed with a cyclic group such as ribofuranose derivative; biotin and 5-carboxyfluorescein derivatives | AFFYMETRIX, INC. | 2003-07-22 | — | — | US | disclosed |
| US-20020165372-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2002-11-07 | — | — | US | disclosed |
| WO-2000006771-A9 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX INC (US) | 2002-08-22 | — | — | WO | disclosed |
| US-20010044531-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2001-11-22 | — | — | US | disclosed |
| US-20010018514-A1 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX, INC. | 2001-08-30 | — | — | US | disclosed |
| EP-1124838-A2 | NUCLEIC ACID LABELING COMPOUNDS | Affymetrix, Inc. (US) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000006771-A2 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX, INC. (US) | 2000-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040002595-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | ALDH1A1 760/4885LMNA 547/4885ALB 3247/4885 |
| US-20050164268-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | ALDH1A1 760/4885LMNA 547/4885ALB 3247/4885 |
| US-20040101892-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | ALDH1A1 760/4885LMNA 547/4885ALB 3247/4885 |
| US-20010044531-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | ALDH1A1 760/4885LMNA 547/4885ALB 3247/4885 |
| US-20050287563-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | ALDH1A1 760/4885LMNA 547/4885ALB 3247/4885 |
| US-20010018514-A1 | NUCLEIC ACID LABELING COMPOUNDS | RNGTT, DUT, FBL | ALDH1A1 760/4885LMNA 547/4885ALB 3247/4885 |
| US-20020165372-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | ALDH1A1 760/4885LMNA 547/4885ALB 3247/4885 |
| US-20030232979-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | ALDH1A1 760/4885LMNA 547/4885ALB 3247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.